Nuvectis Pharma, Inc.

NASDAQ:NVCT

6.77 (USD) • At close June 14, 2024
Bedrijfsnaam Nuvectis Pharma, Inc.
Symbool NVCT
Munteenheid USD
Prijs 6.77
Beurswaarde 124,270,526
Dividendpercentage 0%
52-weken bereik 5.85 - 18.43
Industrie Biotechnology
Sector Healthcare
CEO Mr. Ron Bentsur M.B.A.
Website https://www.nuvectis.com

An error occurred while fetching data.

Over Nuvectis Pharma, Inc.

Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the

Vergelijkbare Aandelen

Kamada Ltd. logo

Kamada Ltd.

KMDA

4.23 USD

Alpha Teknova, Inc. logo

Alpha Teknova, Inc.

TKNO

1.7 USD

Altimmune, Inc. logo

Altimmune, Inc.

ALT

6.11 USD

XOMA Corporation logo

XOMA Corporation

XOMA

25.28 USD

G1 Therapeutics, Inc. logo

G1 Therapeutics, Inc.

GTHX

2.78 USD

Sutro Biopharma, Inc. logo

Sutro Biopharma, Inc.

STRO

3.46 USD

Semler Scientific, Inc. logo

Semler Scientific, Inc.

SMLR

38.32 USD

Entrada Therapeutics, Inc. logo

Entrada Therapeutics, Inc.

TRDA

15.78 USD

Accuray Incorporated logo

Accuray Incorporated

ARAY

1.73 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)